Trending...
- DuoKey to Unveil Encrypted Financial Intelligence Use Case at GISEC Global 2025
- Michelle Kerr Makes Strategic Investment in Summit
- Meditech International Inc. and Los Angeles Rams Continue Strategic Partnership to Enhance Athlete Performance and Recovery
SHF 2.0 Framework as Practical Solution to Drive Continuous Improvement
MIDDLETOWN, N.Y. - OhioPen -- Ongoing research reveals a notable gap between present practices and the essential best practices needed for successful Human Factors Engineering (HFE) projects. This underlines a significant obstacle within the medical device industry – the ineffective implementation of HFE. The issue has become more apparent in recent years, as the Food and Drug Administration (FDA) now reviews HFE project results as part of their quality system regulation (QSR). Disturbingly, over 90% of HFE submissions are reportedly rejected by the FDA, due to deficiencies.
The Critical Role of Human Factors Engineering (HFE) in the Medical Device Industry
Human Factors Engineering (HFE) has a pivotal role in the medical device industry, serving as the intersection of human capabilities and system operations. It significantly contributes to safety, efficiency, and user experience. However, project failure can result in device designs that jeopardize effective and safe usage.
Pioneering this area of research, Dr. Katia M. Rojas, an expert in project management and operational excellence, has been studying the underlying causes of these project failures. Her groundbreaking research began during her Ph.D. studies in Industrial & Systems Engineering at Binghamton University.
Dr. Rojas' work has unveiled substantial insights into the root causes of failures and the crucial success factors in FDA HFE validation projects. Such observations have led her to assert that HFE validations are currently project managed at relatively low maturity levels, which significantly impacts project quality and success rates. This emphasizes the need for an industry-focused project management maturity framework to facilitate the standardization of emerging best practices.
More on Ohio Pen
"By focusing on improving project management maturity, particularly emphasizing the key success factors or best practices, we can drastically cut down the current 90% rejection rate at the FDA," said Dr. Rojas. "This approach not only addresses the pressing challenges in the medical device industry, but also promises improved project outcomes and enhanced patient safety."
Unveiling a Silent Crisis: Importance of Addressing Findings
In the fast-paced world where innovation and patient safety converge, patients are heavily reliant on the successful application of human factors engineering during medical device development. However, "the unsatisfactory application of HFE has subtly transformed into a silent crisis," Dr. Rojas pointed out.
The alarming FDA rejection rates highlight the urgent need for proactive engagement from key stakeholders to implement corrective measures. Nevertheless, the lack of such engagement raises concerns about the effectiveness of any current interventions aimed at reducing the persistently high failure rate.
Introducing the Successful Human Factors™ 2.0 (SHF 2.0) Framework
To address these challenges, Dr. Rojas introduces the Successful Human Factors™ 2.0 (SHF 2.0) framework. SHF 2.0 is a researched-based maturity framework designed to optimize HF projects by focusing on key success factors, particularly those related to the delivery of an HFE Validation Report for FDA review. This approach will enable HF service providers (HFSPs) to refine their processes, establish consistent practices, and uphold the highest standards in medical device HFE.
Effectiveness of the SHF 2.0 Framework in Enhancing HF Project Management Maturity
A study investigating the effectiveness of the SHF 2.0 framework found that the average maturity level of successful HF projects corresponded to "Level 2 – Childhood" in the framework, revealing significant variations and a lack of standardization in implementing HFE best practices for medical devices. These findings underline the urgent need for a more standardized and consistent approach in the field.
More on Ohio Pen
Initial investigations validating the SHF 2.0 framework have demonstrated its potential and reliability as a tool for improving the maturity of HF project management. Participants of the study recognized its potential to enhance the success rates of HF submissions.
These key findings have been consolidated in a pre-print publication titled "Validating a Project Management Maturity Framework Based on Emerging Best Practices for Successful Human Factors Projects Requiring FDA Approval – Summary of Key Findings," which is available on ResearchGate.
Future Outlook: Ongoing Research and Embracing the Long Road Ahead
"While the urgent need for improved HF project management practices in the medical device industry is apparent, stakeholders may still be in the early stages of understanding the value of the SHF 2.0 framework," Dr. Rojas noted, acknowledging the long journey ahead. "Broader adoption of the SHF 2.0 framework can significantly improve HF project outcomes, contributing to progress in HFE within the medical device industry."
The SHF 2.0 framework is designed for continuous improvement, encouraging HFSPs to benchmark their performance against industry standards and best practices. This drive towards excellence fosters innovation and creates new industry benchmarks.
To learn more about SHF 2.0, participate in ongoing industry-wide benchmark research, or explore the current industry maturity level report, visit: https://www.successfulhf.com/
The Critical Role of Human Factors Engineering (HFE) in the Medical Device Industry
Human Factors Engineering (HFE) has a pivotal role in the medical device industry, serving as the intersection of human capabilities and system operations. It significantly contributes to safety, efficiency, and user experience. However, project failure can result in device designs that jeopardize effective and safe usage.
Pioneering this area of research, Dr. Katia M. Rojas, an expert in project management and operational excellence, has been studying the underlying causes of these project failures. Her groundbreaking research began during her Ph.D. studies in Industrial & Systems Engineering at Binghamton University.
Dr. Rojas' work has unveiled substantial insights into the root causes of failures and the crucial success factors in FDA HFE validation projects. Such observations have led her to assert that HFE validations are currently project managed at relatively low maturity levels, which significantly impacts project quality and success rates. This emphasizes the need for an industry-focused project management maturity framework to facilitate the standardization of emerging best practices.
More on Ohio Pen
- Pathways to Adulthood Conference May 17 at Melville Marriott Honoring NYS Assembly Member Jodi Giglio, Suffolk County Legislator Nick Caracappa
- Adster Techologies awarded US Patent for breakthrough innovation in reducing latency in Ad Serving
- Robert Fabbio Inducted into the Austin Technology Council Hall of Fame
- KRATON ANNOUNCES DECISION TO EXIT DOVER SITE TO FOCUS ON CORE BUSINESS GROWTH
- Goodyear Completes Sale of Dunlop Brand
"By focusing on improving project management maturity, particularly emphasizing the key success factors or best practices, we can drastically cut down the current 90% rejection rate at the FDA," said Dr. Rojas. "This approach not only addresses the pressing challenges in the medical device industry, but also promises improved project outcomes and enhanced patient safety."
Unveiling a Silent Crisis: Importance of Addressing Findings
In the fast-paced world where innovation and patient safety converge, patients are heavily reliant on the successful application of human factors engineering during medical device development. However, "the unsatisfactory application of HFE has subtly transformed into a silent crisis," Dr. Rojas pointed out.
The alarming FDA rejection rates highlight the urgent need for proactive engagement from key stakeholders to implement corrective measures. Nevertheless, the lack of such engagement raises concerns about the effectiveness of any current interventions aimed at reducing the persistently high failure rate.
Introducing the Successful Human Factors™ 2.0 (SHF 2.0) Framework
To address these challenges, Dr. Rojas introduces the Successful Human Factors™ 2.0 (SHF 2.0) framework. SHF 2.0 is a researched-based maturity framework designed to optimize HF projects by focusing on key success factors, particularly those related to the delivery of an HFE Validation Report for FDA review. This approach will enable HF service providers (HFSPs) to refine their processes, establish consistent practices, and uphold the highest standards in medical device HFE.
Effectiveness of the SHF 2.0 Framework in Enhancing HF Project Management Maturity
A study investigating the effectiveness of the SHF 2.0 framework found that the average maturity level of successful HF projects corresponded to "Level 2 – Childhood" in the framework, revealing significant variations and a lack of standardization in implementing HFE best practices for medical devices. These findings underline the urgent need for a more standardized and consistent approach in the field.
More on Ohio Pen
- Cybersecurity is Protecting Your Personal Information and Your Portfolio
- L2 Aviation Celebrates Grand Opening of New Facility at Cincinnati/Northern Kentucky International Airport (CVG)
- Managing Summer Staffing Surges with Confidence: Why Name Badges Are a Must for Seasonal Success
- Visa Named Title Sponsor of Ascending Athletes' Business Owners Summits for NFL Entrepreneurs
- The Paris Court of International Arbitration Elects Dr. John J. Maalouf as its New President
Initial investigations validating the SHF 2.0 framework have demonstrated its potential and reliability as a tool for improving the maturity of HF project management. Participants of the study recognized its potential to enhance the success rates of HF submissions.
These key findings have been consolidated in a pre-print publication titled "Validating a Project Management Maturity Framework Based on Emerging Best Practices for Successful Human Factors Projects Requiring FDA Approval – Summary of Key Findings," which is available on ResearchGate.
Future Outlook: Ongoing Research and Embracing the Long Road Ahead
"While the urgent need for improved HF project management practices in the medical device industry is apparent, stakeholders may still be in the early stages of understanding the value of the SHF 2.0 framework," Dr. Rojas noted, acknowledging the long journey ahead. "Broader adoption of the SHF 2.0 framework can significantly improve HF project outcomes, contributing to progress in HFE within the medical device industry."
The SHF 2.0 framework is designed for continuous improvement, encouraging HFSPs to benchmark their performance against industry standards and best practices. This drive towards excellence fosters innovation and creates new industry benchmarks.
To learn more about SHF 2.0, participate in ongoing industry-wide benchmark research, or explore the current industry maturity level report, visit: https://www.successfulhf.com/
Source: Successful Human Factors™
0 Comments
Latest on Ohio Pen
- 20 Patents Issued Worldwide, Cementing Company Leadership. First Ever Cable-Free 12-Lead ECG: HeartBeam, Inc. (Stock Symbol: BEAT)
- NASDAQ Uplisting for Higher Market Exposure and Wide Corporate Benefits to AI Boosted Marketing Company On Track Towards $1 Billion Revenue by 2027
- Congressional Men's Health Caucus Shows Bipartisan Consensus and Focus on Prevention, Mental Health, and Closing the Lifespan Gap
- Trailhead Biosystems Secures $20 Million to Drive Innovation and Accelerate Growth
- DuoKey, Axiomtek and Blue Edge Network Partner to Enhance Smart Cities with Privacy-Preserving Urban Safeguarding and Fleet Management
- Cogent Communications Faces Federal Scrutiny Over Fraudulent Acquisition and 22-Year Corporate Cover-Up
- Austin Keen Joins WakeFX RopePal as Official Brand Ambassador
- Columbus: Clean and Safe Corridors Initiative Takes Place on Sullivant Avenue
- Bonelli Systems Expands Managed IT Services Nationwide, Leveraging Microsoft Azure Expertise
- $4.3 Million Patent Application Waiver Fee Granted by FDA on New Drug Application Fee for Treatment Addressing Suicidal Depression & PTSD: NRX Pharma
- Whistleblower Claims Dental Patient Deaths Likely Due to Book Ban
- xREnergy up as much as +3,094,634% on first day listed on the XRP Ledger. Ticker : $XRE
- Psychiatry's Legacy of Racism and Coercion Highlighted in Restraint Deaths
- New Book 'Cybersecurity Leadership' Guides SME Leaders to Make Smart, Strategic Security Decisions
- Adsposure Announces Winners of Annual Transit Awards
- "Stop scrolling and start watching" - Beloved film recommendation site Criticker gets a major makeover
- Green Energy Solar Expands with New Offices in Port St. Lucie, West Palm Beach, and Orlando
- Events by Dubsdread Expands Services to The Venue at Lake Lily
- London Gala Emphasizes Trade, FDI and Ongoing Cooperation
- SingOUT Cincy hosts Festival celebrating LGBTQIA+ music and performers in Greater Cincinnati